CAGNETTI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.573
EU - Europa 907
AS - Asia 176
AF - Africa 82
Totale 2.738
Nazione #
US - Stati Uniti d'America 1.568
IT - Italia 361
UA - Ucraina 143
IE - Irlanda 97
SE - Svezia 86
DE - Germania 63
CI - Costa d'Avorio 61
SG - Singapore 55
CN - Cina 50
FR - Francia 49
DK - Danimarca 45
TR - Turchia 41
GB - Regno Unito 26
KR - Corea 21
MA - Marocco 21
FI - Finlandia 20
RO - Romania 10
CA - Canada 5
IN - India 5
NL - Olanda 5
JP - Giappone 2
VN - Vietnam 2
EE - Estonia 1
LV - Lettonia 1
Totale 2.738
Città #
Chandler 186
Fairfield 171
Jacksonville 151
Ashburn 135
Dublin 95
Seattle 84
Boardman 72
Houston 70
Wilmington 70
Woodbridge 68
Abidjan 61
Redmond 51
New York 48
Cambridge 45
Des Moines 39
Lawrence 37
Princeton 37
San Mateo 33
Turin 28
Ann Arbor 27
San Diego 25
Centro 21
Singapore 19
Milan 17
Porto 16
Rome 15
London 9
Timisoara 9
Beijing 8
Cagliari 8
Genoa 8
Washington 8
Naples 7
Noisy-le-sec 7
Civitanova Marche 6
Florence 6
Ancona 5
Bonn 5
Helsinki 5
Padova 5
Pune 5
San Casciano In Val Di Pesa 5
Tolentino 5
Dallas 4
Kilburn 4
Los Angeles 4
Macerata 4
Ripa Teatina 4
Squinzano 4
Villar Perosa 4
Fermo 3
Guangzhou 3
Hounslow 3
Islington 3
Jinhua 3
Little Rock 3
Matelica 3
Norwalk 3
Ottawa 3
Rivoli 3
Santa Ana 3
Auburn Hills 2
Bari 2
Bologna 2
Cantu 2
Carugate 2
Castelletto Stura 2
Desio 2
Dong Ket 2
East Peoria 2
Ferentino 2
Frankfurt am Main 2
Grugliasco 2
Hefei 2
Isola del Liri 2
Jiaxing 2
Marche 2
Mediglia 2
Monza 2
Napoli 2
Palermo 2
Pavia 2
Pesaro 2
Piossasco 2
Pisa 2
Prescot 2
Redwood City 2
Salerno 2
Savigliano 2
Termeno 2
Toronto 2
Venice 2
Acerenza 1
Acton 1
Argelato 1
Barchi 1
Cantù 1
Chizhou 1
Constanta 1
Cormeilles-en-Parisis 1
Totale 1.863
Nome #
Distrofia miotonica tipo 1 (Malattia di Steinert) e disturbi del sonno: prevalenza e severità dei disturbi respiratori durante il sonno al momento della diagnosi e scarsa consapevolezza da parte del paziente 227
Endovascular treatment and cognitive outcome after anterior circulation ischemic stroke 122
Neutrophil-to-lymphocyte ratio improves outcome prediction of acute intracerebral hemorrhage 105
Brivaracetam add-on for refractory focal epilepsy 104
Blood pressure variability and clinical outcome in patients with acute intracerebral hemorrhage 102
Neurocognitive functioning and cerebrovascular reactivity after carotid endarterectomy 94
Brivaracetam as add-on treatment in focal epilepsy: A real-world time-based analysis 89
Progressive Multifocal Myelopathy or Multiple Sclerosis? 88
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis 87
The P-wave terminal force in embolic strokes of undetermined source 86
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis 83
Imitation strategies of callosotomized patients. 82
Neutrophil-to-Lymphocyte Ratio Predicts the Outcome of Acute Intracerebral Hemorrhage 79
Skin features in myotonic dystrophy type 1: An observational study 77
Patent Foramen Ovale and Cryptogenic Stroke or Transient Ischemic Attack: To Close or Not to Close? A Systematic Review and Meta-Analysis 72
Predictors of cognitive functioning after carotid revascularization 72
Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy 71
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis 71
Lacosamide monotherapy for partial onset seizures 70
Palliative non-resective surgery for drug-resistant epilepsy 69
Neutrophil-to-Lymphocyte Ratio in Acute Cerebral Hemorrhage: a System Review 68
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 67
Endovascular treatment of symptomatic vertebral artery stenosis: A systematic review and meta-analysis 67
Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage 65
Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: An evidence-based review of efficacy, safety and place in therapy 65
Atopic myelitis is not restricted to Japanese patients 64
How Should We Lower Blood Pressure after Cerebral Hemorrhage? A Systematic Review and Meta-Analysis 64
Neurogenic muscle hypertrophy. 62
Lacosamide during pregnancy and breastfeeding 58
Predictors of Pharmaco-Resistance in Patients with Post-Stroke Epilepsy 58
Psychiatric comorbidities in patients from seven families with autosomal dominant cortical tremor, myoclonus, and epilepsy 56
Mystery case responses 52
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis 52
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 49
The latency of post-stroke epilepsy can predict drug resistance 43
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 37
Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice 36
Individualized Prediction of Drug Resistance in People with Post-Stroke Epilepsy: A Retrospective Study 23
Totale 2.836
Categoria #
all - tutte 15.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020162 0 0 0 2 33 0 36 2 37 0 5 47
2020/2021732 53 48 76 17 75 86 59 42 65 110 66 35
2021/2022335 33 61 21 5 8 23 11 18 13 39 28 75
2022/2023609 52 72 58 35 30 78 3 36 142 4 81 18
2023/2024446 62 17 36 60 68 88 11 27 15 13 12 37
2024/2025208 104 78 26 0 0 0 0 0 0 0 0 0
Totale 2.836